Skip to main content

Table 1 Common indications for rituximab therapy

From: Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective

Disease conditions
Chronic lymphocytic leukemia
CD20+ non-Hodgkin lymphoma (expressing the B-lymphocyte antigen CD20)
Rheumatoid arthritis
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
   • Granulomatosis with polyangiitis (formerly Wegener's granulomatosis)
   • Microscopic polyangiitis
   • Eosinophilic granulomatosis associated with polyangiitis (formerly Churg-Strauss syndrome) (unlabeled)
Chronic refractory graft-versus-host disease (unlabeled)
Refractory idiopathic thrombocytopenic purpura (unlabeled)
Hodgkin lymphoma (unlabeled)
Refractory pemphigus vulgaris (unlabeled)
Post-transplant lymphoproliferative disorder (unlabeled)
Waldenström macroglobulinemia (unlabeled)
Type I diabetes mellitus (unlabeled)
Multiple sclerosis (unlabeled)
Renal transplant (unlabeled)